Literature DB >> 3536383

A review of alprazolam withdrawal.

J L Browne, K J Hauge.   

Abstract

A cumulative review of case reports in the literature describing withdrawal reactions secondary to alprazolam is presented. In four of eight reports, the primary withdrawal manifestations were grand mal seizures. One case was characterized by painful myoclonus. In the remaining three cases, the major complications consisted of rebound anxiety with psychotic features. Despite tapering of the daily dosage according to manufacturer guidelines, a withdrawal syndrome was precipitated in three of the cases. As a result of alprazolam's atypical pharmacodynamic profile, the issue is raised as to whether alprazolam is pharmacologically cross-tolerant with other benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536383     DOI: 10.1177/106002808602001102

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  9 in total

1.  Alprazolam use and dependence. A retrospective analysis of 30 cases of withdrawal.

Authors:  B Dickinson; P A Rush; A B Radcliffe
Journal:  West J Med       Date:  1990-05

Review 2.  A Review of Alprazolam Use, Misuse, and Withdrawal.

Authors:  Nassima Ait-Daoud; Allan Scott Hamby; Sana Sharma; Derek Blevins
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

Review 3.  Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment.

Authors:  R C Turner; P R Lichstein; J G Peden; J T Busher; L E Waivers
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

Review 4.  Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring.

Authors:  Anna Basińska-Szafrańska
Journal:  Eur J Clin Pharmacol       Date:  2021-01-03       Impact factor: 2.953

Review 5.  A risk-benefit assessment of buspirone in the treatment of anxiety disorders.

Authors:  J C Pecknold
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

6.  Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

Authors:  M Linnoila; J M Stapleton; R Lister; H Moss; E Lane; A Granger; M J Eckardt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 7.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 8.  Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.

Authors:  S I Ankier; K L Goa
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

9.  Failure of lorazepam to treat alprazolam withdrawal in a critically ill patient.

Authors:  Gaurav Sachdev; Gail Gesin; A Britton Christmas; Ronald F Sing
Journal:  World J Crit Care Med       Date:  2014-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.